Petrie-Flom Center: Health Law, Biotech and Bioethics

Dalia Deak ’19 is this year’s winner of the individual David Grossman Exemplary Clinical Award, given each year to the student who embodies the pro bono spirit of the late professor and exemplifies putting theory into practice through clinical work.

In a lecture titled “The Second Reproductive Revolution,” I. Glenn Cohen, the faculty director of the Petrie-Flom Center, marked his appointment as the first James A. Attwood and Leslie Williams Professor of Law.

A recent event at Harvard Law School brought together scientists and lawyers to start a dialogue on neuroscience, trauma, and justice as part of the Project on Law and Applied Neuroscience, a collaboration between the Petrie-Flom Center at HLS and Massachusetts General Hospital.

Harvard researchers—including HLS Professor and Petrie-Flom Center Faculty Director Glenn Cohen—and others share their views on key issues in the field.

The Wall Street Journal investigative reporter whose new book chronicles the spectacular collapse of the blood-testing company Theranos and its alleged fraudulent activity told a Harvard audience that the fall is a cautionary tale for other high-tech firms aspiring to disrupt the health care industry.

Last week, Harvard commemorated the centennial of the 1918 influenza pandemic that killed more than 50 million people worldwide with Outbreak Week, a series of events across the university.

During the introduction to the book launch event for “Big Data, Health Law, and Bioethics,” one of the editors, Harvard Law School Professor I. Glenn Cohen ’03, faculty director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, told a story about how powerful – and perhaps foreboding – big data can be.

Maayan Sudai, an S.J.D. candidate at Harvard Law School, has been awarded a prestigious scholarship from Israel’s Dan David Foundation to support her work examining health activism from a legal perspective.

On Jan. 23, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen launched a new collaboration, the Project on Precision Medicine, Artificial Intelligence, and the Law (PMAIL).

This fall, the Harvard Law School Library hosted a series of book talks by HLS authors, with topics ranging from Justice and Leadership in Early Islamic Courts to a Citizen's Guide to Impeachment. As part of this ongoing series, faculty authors from various disciplines shared their research and discussed their recently published books.

This fall, Glenn Cohen, Harvard Law School professor and faculty director for the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics delivered a talk titled “Are There Non-human Persons? Are There Non-person Humans?,” which explored how law and morality should accommodate animals and artificial intelligence alongside human beings.

Harvard Law School Professor Einer Elhauge ’86 will receive the prestigious Jerry S. Cohen Award for Antitrust Scholarship from the American Anititrust Institute at their annual conference on June 21.

While the NFL’s player health policies and practices are robust in some areas, there are opportunities for improvement in others, according to the findings of a new report by researchers at Harvard Law School's Petrie-Flom Center -- the first comprehensive comparative analysis of health policies and practices across professional sports leagues.

On March 23, William B. Schultz, former general counsel of the U.S. Department of Health and Human Services (2011-2016), discussed the complicated politics surrounding the Affordable Care Act and possible policy options for the next phase of the law’s evolution.

Harvard Law School Professor Glenn Cohen co-authored an article for the journal Science Translational Medicine on the legal and ethical considerations regarding in vitro gametogenesis (IVG), a new, experimental technique that allows scientists to grow embryos in a lab by reprograming adult cells to become sperm and egg cells.

The Football Players Health Study at Harvard University today released a set of legal and ethical recommendations to address a series of structural factors that affect NFL player health. The Football Players Health Study is a research initiative composed of several ongoing studies examining the health and wellbeing of NFL players.

Professor Glenn Cohen breaks down complex topic for Ed Portal and online audience.

The Coalition to Transform Advanced Care (C-TAC), a non-profit organization with a vision of improving advanced illness care for all Americans, and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School co-hosted the inaugural event for their new collaboration: The Project on Advanced Care and Health Policy.

Harvard Law School Professor I. Glenn Cohen, faculty director of the School's Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics spoke with the Harvard Gazette about Monday's ruling by the Supreme Court that overturned a Texas law requiring that abortion clinics maintain hospital-like standards at their facilities as well as admitting privileges at local hospitals.

On March 29, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School celebrated its first decade and kicked off the next with a conference that focused on the future of health law and policy.

Credit: Johansen Krause William W. Fisher Across HLS, faculty are focusing on international access to lifesaving drugs for underserved populations. One forthcoming book, “The Health…